510(k) Report

510(k) · Cleared

Cleared

Snap Insulin Pump System

K142619510(k) SpecialCleared Dec 18, 201493-day reviewClass II21 CFR 880.5725

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Asante Solutions, Inc. · LZG Pump, Infusion, Insulin

Cleared on Dec 18, 2014 as substantially equivalent to K122483 (Asante Solutions, Inc., 2013) after a 93-day review. Its family tree reaches back 8 generations to 1991.

Decided
Dec 18, 2014
Review
93 days
Class
Class II
Product code
LZG
Recalls
None
Predicates
1

Its longest line of descent runs back 8 generations to K905693 (1991). 9 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 8 generations backK905693 H-Tron V 100 Insulin Infusion PumpDisetronic Medical Systems · 1991 · Recalled
  2. 7 generations backK973044 Disetronic H-Tron Plus V 100 Insulin Infusion PumpDisetronic Medical Systems · 1997 · Recalled
  3. 6 generations backK994186 Disetronic D-Tron Insulin Infusion PumpDisetronic Medical Systems · 1999
  4. 5 generations backK021725 Disetronic D-Tron Insulin Infusion PumpDisetronic Medical Systems AG · 2002
  5. 4 generations backK022831 Modification to Disetronic D-Tronplus Insulin Infusion PumpDisetronic Medical Systems AG · 2002 · Recalled
  6. 3 generations backK043000 Modification to D-TronplusDisetronic Medical Systems AG · 2004 · Recalled
  7. 2 generations backK100567 Pearl Diabetes Management SystemM2 Group Holdings, Inc. · 2011
  8. 1 generation backK122483 Pearl Diabetes Management SystemAsante Solutions, Inc. · 2013
  9. This deviceK142619 Snap Insulin Pump SystemAsante Solutions, Inc. · 2014
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K905693H-Tron V 100 Insulin Infusion PumpDisetronic Medical Systems19911
−7K973044Disetronic H-Tron Plus V 100 Insulin Infusion PumpDisetronic Medical Systems19975
−6K994186Disetronic D-Tron Insulin Infusion PumpDisetronic Medical Systems1999—
−5K021725Disetronic D-Tron Insulin Infusion PumpDisetronic Medical Systems AG2002—
−4K022831Modification to Disetronic D-Tronplus Insulin Infusion PumpDisetronic Medical Systems AG20021
−3K043000Modification to D-TronplusDisetronic Medical Systems AG20042
−2K100567Pearl Diabetes Management SystemM2 Group Holdings, Inc.2011—
−1K122483Pearl Diabetes Management SystemAsante Solutions, Inc.2013—
0 (this device)K142619Snap Insulin Pump SystemAsante Solutions, Inc.2014—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200310
FIG. 1 — Lineage of K142619, 1991–2014Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LZG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LZG device

  1. #1 K253534 Pivot Insulin Delivery Systemscore 16.8 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K122483Pearl Diabetes Management System
Summary page 4
…ump, Infusion, Insulin Product Code: LZG Regulation Number: 880.5725 Class: II Predicate Device Asante Pearl Diabetes Management System (K122483) Intended Use The Snap Insulin Pump System is intended for continuous, subcutaneous delivery of insulin at programmable basal an…
Asante Solutions, Inc.2013—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 4 companies; a new generation was cleared every 2.3 years on median.
  • 5 of the 9 ancestors have a recall of any class.

How does its category compare?

All LZG devices

LZG Pump, Infusion, Insulin: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.

FDA decisions per year · LZG

2in 2024

2007: 32008: 62009: 22010: 22011: 42012: 32013: 22014: 42015: 12016: 42017: 12018: 12019: 22021: 12022: 12023: 12024: 22026 (partial year): 2
2007high 6 (2008) · low 0 (2020)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LZG

116in 2016

2007: 112 days median2008: 129 days median2011: 189 days median2012: 73 days median2014: 123 days median2016: 116 days median
2007high 189 (2011) · low 73 (2012)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LZG

1in 2022

2007: 12008: 132009: 22010: 42011: 22012: 42013: 3, 1 Class I2014: 2, 1 Class I2015: 2, 2 Class I2018: 3, 2 Class I2019: 52022: 1, 1 Class I2026 (partial year): 2, 2 Class I
2007high 13 (2008) · low 0 (2016)2026

Class I (9 since 2007) Class II/III not classified

Adverse event reports per year · LZG

12,004in 2025

2007: 5,1102008: 5,7112009: 9,4712010: 10,1752011: 12,8582012: 18,3672013: 30,0592014: 49,1882015: 69,1362016: 56,5812017: 44,4722018: 32,6522019: 29,0272020: 32,5882021: 31,5222022: 28,2252023: 21,9722024: 18,2282025: 12,004
2007high 69,136 (2015) · low 5,110 (2007)2025

MAUDE reports naming product code LZG, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007311215,110
20086129135,711
20092—29,471
20102—410,175
20114189212,858
2012373418,367
20132—3 (1)30,059
201441232 (1)49,188
20151—2 (2)69,136
20164116056,581
20171—044,472
20181—3 (2)32,652
20192—529,027
20200—032,588
20211—031,522
20221—1 (1)28,225
20231—021,972
20242—018,228
20250—012,004
20262—2 (2)—

What is it indicated for?

The Asante Snap Insulin Pump System is indicated for continuous, subcutaneous delivery of insulin at programmable

basal and bolus rates for the management of diabetes mellitus in adult patients requiring insulin.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K142619: Snap Insulin Pump System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K142619

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026